Core Viewpoint - The report outlines the ongoing supervision and assessment of Hangzhou Anjisi Medical Technology Co., Ltd. by CITIC Securities, focusing on the company's compliance, financial performance, and potential risks in the medical device industry [1][2]. Group 1: Continuous Supervision Overview - CITIC Securities conducted a site inspection on July 14, 2025, as part of its ongoing supervisory responsibilities [1]. - The supervision included reviewing corporate governance documents, financial management systems, and fundraising management practices [1]. Group 2: Identified Issues and Rectification - No major issues were found during the supervision period, indicating effective management practices [2]. - The company faces core competitiveness risks due to the lengthy and complex nature of developing minimally invasive endoscopic devices [2][3]. Group 3: Major Risk Factors - The company is exposed to operational risks from increasing competition in the domestic market and potential price reductions due to healthcare cost control measures [2][4]. - Quality control is critical, as any product defects could harm the company's reputation and financial performance [3][4]. Group 4: Financial Performance - For the first half of 2025, the company reported a revenue of 302.43 million yuan, a 14.56% increase from the previous year [11]. - The total profit for the same period was 149.13 million yuan, reflecting a 2.78% increase [11]. - The net profit attributable to shareholders was 111.51 million yuan, showing a decrease of 7.06% when excluding non-recurring gains [11]. Group 5: Research and Development - The company has increased its R&D investment, with total R&D expenses reaching 34.46 million yuan, a 33.29% increase compared to the previous period [18]. - R&D efforts focus on innovative diagnostic and therapeutic devices, with a strong emphasis on integrating AI technologies [12][18]. Group 6: Market Dynamics - The company is expanding its market presence, with significant sales growth in Europe (38.28%) and Asia (29.05%), while facing a decline in North America (9.89%) due to trade tensions [16]. - The company actively adapts to new procurement policies and payment regulations in the healthcare sector to maintain competitiveness [8][9]. Group 7: Compliance and Governance - The company adheres to various international and domestic quality management standards, ensuring compliance in its operations [13]. - There were no significant violations of fundraising regulations during the supervision period, indicating sound financial governance [21][24].

Market Overview - The global endoscope market is experiencing steady growth, with projections indicating a market size exceeding $25.37 billion by 2024 and a compound annual growth rate (CAGR) of 5.3% until 2037, potentially reaching over $49.65 billion [1] - Different research firms provide varying estimates, with Global Market Insights forecasting a market value of $29 billion in 2024, growing to $56.9 billion by 2034, reflecting a CAGR of 6.9% [1] - The market is also expected to reach a sales scale of 283 billion yuan in 2024, with a forecasted growth to 387.64 billion yuan by 2030, indicating a CAGR of 7.4% [1] Market Segmentation - The flexible and rigid endoscope segments show strong growth potential, with the flexible endoscope market projected to grow from $8.98 billion in 2023 to $16.73 billion by 2033, at a CAGR of 6.42% [2] - The rigid endoscope market is expected to grow from $7.4 billion in 2023 to $14.7 billion by 2033, with a CAGR of 7.1% [2] - The single-use endoscope market is anticipated to grow rapidly, with a projected value of $4.57 billion in 2024, increasing to $5.43 billion in 2025, and reaching $21.86 billion by 2033, reflecting a CAGR of 19.01% [2] Key Market Drivers and Challenges - The rise in chronic diseases, particularly gastrointestinal diseases and cancers, is a significant driver for the endoscope market, with the WHO reporting 2.05 million deaths from cardiovascular diseases in 2021 [3] - Technological advancements in endoscope imaging, such as 4K and 8K imaging, narrow-band imaging, and AI integration, enhance diagnostic accuracy and treatment effectiveness [3] - The increasing prevalence of minimally invasive surgery (MIS) is also a key factor, as endoscopes are essential tools in these procedures [3] - Challenges include patient risks associated with endoscopic procedures, a shortage of trained professionals, and high costs of equipment, particularly in developing regions [4] Regional Market Analysis - North America leads the global endoscope market, valued at $19.2 billion in 2022, and is expected to account for about 40% of global revenue by 2037 [5] - The Asia-Pacific region is recognized as the fastest-growing market, driven by a large population, increasing economic strength, and rising healthcare awareness [6] - Europe holds a significant market share of approximately 28%, with strong markets in Germany and France due to advanced healthcare systems [7] Competitive Landscape - The endoscope market is highly concentrated, dominated by major multinational companies such as Olympus, Fujifilm, Karl Storz, and Stryker, which excel in technology development and product innovation [8] - Olympus leads the flexible endoscope market with a global market share of about 60% in 2024, while Karl Storz is a key player in the rigid endoscope segment [10][11] - The market is characterized by intense competition, with companies focusing on technological innovation, product performance, and pricing strategies [14] Technological Advancements - Recent advancements in imaging technology, including 4K and 3D imaging, are crucial for enhancing diagnostic capabilities [15] - The introduction of single-use endoscopes addresses issues of cross-infection and maintenance costs, with a significant increase in market presence since 2020 [17] - Capsule endoscopy technology allows for non-invasive examination of hard-to-reach areas, providing significant diagnostic advantages [20] Clinical Applications - Endoscopes are widely used across various medical fields, including gastroenterology, pulmonology, urology, gynecology, and general surgery, demonstrating their critical role in modern medicine [21] - The technology offers minimally invasive options, reducing recovery times and improving patient outcomes [22] - The penetration rate of endoscopic technology varies globally, with developed countries showing higher usage rates compared to developing regions [24][25] Future Outlook - The global endoscope market is expected to maintain robust growth, driven by aging populations, chronic disease burdens, and ongoing technological innovations [29] - The single-use endoscope market is projected to see explosive growth, particularly in infection control-sensitive areas [29] - AI integration in endoscopy is anticipated to enhance diagnostic accuracy and operational efficiency [30]